4 completed. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 1 | Completed 1 |
Follow emixustat: new trials by email Literature Review of emixustat trials Research Report on emixustat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease Emixustat - Stargardt Disease, Macular Atrophy | Phase 2 | Completed | Kubota Vision Inc. | 23 | 2017-01-01 | 2021-05-19 |
| Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy emixustat hydrochloride, Placebo - Proliferative Diabetic Retinopathy | Phase 2 | Completed | Kubota Vision Inc. | 24 | 2016-05-01 | 2021-05-19 |
| Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride ACU-4429, Placebo - Geographic Atrophy | Phase 2 / Phase 3 | Completed | Kubota Vision Inc. | 508 | 2013-02-01 | 2017-07-02 |
| Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy ACU-4429, Matching placebo - Dry Age-related Macular Degeneration, Geographic Atrophy | Phase 2 | Completed | Kubota Vision Inc. | 72 | 2009-10-01 | 2014-03-11 |
Geographic Atrophy (2) · Anetoderma (1) · Stargardt Disease (1)
United States (4)